China Drug Distributor Sinopharm To Sell Shares To Expand Sales Network
This article was originally published in PharmAsia News
Executive Summary
China's major drug distributor, Sinopharm Group, plans to sell shares to raise U.S.$515.3 million to enable expansion of its sales network as part of an effort an analyst said was needed to enable the firm to continue growing.